Providing Targeted Cancer Diagnostics

Clinical Trials Service

UCL-AD's team of scientists

  • Provide assistance and technical input into trial specific laboratory testing manuals to help effective transition into active trial program.

  • Create comparable SOPs integrated into local quality system ensuring testing compliance.

  • Offer a GCP trained UCL-AD study co-ordinator assigned to each study to liaise and organise prompt result returns and assist with any queries for the duration of the trial.

Optima - Breast Cancer

Optimal Personalised Treatment of early breast cancer usIng Multi-parameter Analysis.  OPTIMA is a partially-blind randomised trial designed to compare clinical and economic outcomes of standard chemotherapy treatment with biomarker-directed allocation to chemotherapy or no chemotherapy in women with ER positive, HER2 negative breast cancer and either axillary node involvement or larger tumours.